Breaking News: Virbac Reveals Share and Voting Numbers for 2025!
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS
Information on the total number of voting rights and of shares representing the share capital
(Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers)
Quotation place: Euronext Paris
Compartiment A
ISIN code: FR0000031577
Date | Total number of shares representing the share capital | Total number of voting rights
December, 31, 2024 | 8,390,660 | Gross total of voting rights: 12,707,315 Net total* of voting rights: 12,691,249
Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.
VIRBAC: Shaping the future of animal health
NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP
Corporate Finance: tel.
Virbac, a leading company in animal health, has recently unveiled the share and voting numbers for the year 2025. With a total number of shares representing the share capital at 8,390,660 and a gross total of voting rights of 12,707,315, it is evident that Virbac is shaping the future of animal health with its strategic decisions and strong market presence. The net total of voting rights stands at 12,691,249, emphasizing the importance of shareholder participation and corporate governance within the company.
As a key player in the animal health industry, Virbac continues to innovate and develop new products and solutions to address the evolving needs of pets and livestock. With a focus on research and development, as well as collaboration with veterinary professionals, Virbac remains committed to improving the well-being of animals worldwide.
Overall, the disclosure of share and voting numbers for 2025 is a reflection of Virbac’s transparency and commitment to financial disclosure. Investors and stakeholders can have confidence in the company’s governance structure and long-term growth prospects.
Effect on Me:
The revelation of Virbac’s share and voting numbers for 2025 can impact me as an individual investor by providing insight into the company’s financial standing and market performance. As a shareholder, I can use this information to make informed decisions about my investment portfolio and assess the potential risks and returns associated with owning Virbac stock.
Effect on the World:
Virbac’s disclosure of share and voting numbers for 2025 has a broader impact on the world by highlighting the importance of corporate transparency and accountability in the animal health industry. By sharing this information publicly, Virbac sets an example for other companies to prioritize governance practices and ethical standards, ultimately benefiting the global community of investors, consumers, and stakeholders.
Conclusion:
In conclusion, Virbac’s announcement of share and voting numbers for 2025 underscores the company’s commitment to transparency and shareholder engagement. By sharing this information, Virbac demonstrates its dedication to financial integrity and responsible corporate governance, setting a positive example for the industry and the global business community as a whole.
